Reactor cooling is critical to the production of API’s used in Ibuprofen at this pharmaceutical plant. Reliability issues of their existing chillers were reducing their cooling capabilities and threatening to halt production completely. The brine in the reactors needed to be kept at -15ºF to avoid solids forming and the brine quality falling. Other providers could not offer a -15ºF temporary solution due to the complexity of the technology. To ensure full capacity, they needed a solution that could achieve -15ºF output that could be engineered and quickly installed.